Cellectis (NASDAQ: CLLS) reported Q1 EPS of (EUR0.84), EUR0.44 worse than the analyst estimate of (EUR0.40). Revenue for the quarter came in at EUR9.5 million versus the consensus estimate of EUR10.3 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.